文献速递其他结缔组织病血管炎

结缔组织病相关肺动脉高压筛查与诊断方法更新

Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.
PubMed 文献 · Semin Arthritis Rheum · 2018-10-14

多数研究为系统性硬化症队列,复合筛查工具(DETECT、ASIG)及TRV联合肺功能变量较2009年ESC/ERS指南或单用TRV有更高敏感性和阴性预测值。

要点

  • 结缔组织病相关PAH筛查证据主要来自系统性硬化症队列。
  • DETECT和ASIG在不同队列中敏感性和阴性预测值优于2009年ESC/ERS指南。
  • TRV联合DLCO或FVC/DLCO比值较单用TRV敏感性和阴性预测值更高。

核心结论

  • 当前CTD相关PAH筛查以SSc为核心,数据继续支持TTE并新增复合筛查工具的证据。

研究设计与样本

  • 纳入研究包括16项SSc队列研究和6项病例对照研究(SSc 4项,SLE 2项),偏倚风险多用QUADAS-2工具评估。

主要发现

  • 4项SSc队列研究仅评估经胸超声心动图(TTE),8项SSc队列研究评估复合指标包括ASIG、DETECT及TRV联合肺功能变量。
  • DETECT和ASIG在不同队列中较2009年ESC/ERS指南有更高敏感性和阴性预测值。
  • TRV联合DLCO或FVC/DLCO比值较单用TRV有更高敏感性和阴性预测值。

关键数值与推荐

  • DETECT和ASIG在不同队列中较2009年ESC/ERS指南敏感性及阴性预测值更高。
  • TRV联合DLCO或FVC/DLCO比值较单用TRV敏感性及阴性预测值更高。

临床怎么用

  • 对SSc患者应继续使用TTE筛查PAH,并可考虑DETECT、ASIG等复合工具或TRV联合肺功能变量以提高检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pulmonary arterial hypertension (PAH) has high morbidity and mortality in connective tissue diseases (CTDs), especially systemic sclerosis (SSc). In this systematic review, we provide an update on screening measures for early detection of PAH in CTD. METHODS: Manuscripts published between July 2012 and October 2017, which incorporated screening measures to identify patients with PAH by right heart catheterization, were identified. Risk of bias was assessed using the QUADAS-2 tool. RESULTS: The systematic review resulted in 1514 unique citations and 22 manuscripts were included for final review; the majority of manuscripts had a lower risk of bias based on the QUADAS-2 tool. There were 16 SSc cohort studies and 6 case-control studies (SSc 4, SLE 2). Four SSc cohort studies evaluated transthoracic echocardiography (TTE) only. Eight SSc cohort studies evaluated composite measures including ASIG, DETECT, and a combination of tricuspid regurgitation velocity (TRV) and PFT variables. DETECT and ASIG had greater sensitivity and negative predictive value (NPV) compared to the 2009 ESC/ERS guidelines in different cohorts. The addition of PFT variables, such as DLCO or FVC/ DLCO ratio, to TRV, resulted in greater sensitivity and NPV compared to TRV alone. CONCLUSION: Current screening for PAH in CTDs is centered on SSc. Data continues to support the use of TTE and provides additional evidence for use of composite measures.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Young A, Nagaraja V, Basilious M, et al. Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. Semin Arthritis Rheum. 2018. PMID: 30415942. doi:10.1016/j.semarthrit.2018.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。